Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
The Sainsbury Laboratory is managing 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 3 actions are assigned to 3 distinct examiners, meaning each examiner is currently handling 1 matter for the laboratory. This distribution shows that the current prosecution workload is spread across multiple individuals at the patent office, preventing a concentration of the laboratory's matters under a single examiner.
The portfolio spans 2 distinct art units, indicating that the 3 pending office actions are grouped within 2 technical classifications. DEVEAU ROSEN, JASON is the busiest examiner for the portfolio, with 1 pending office action. This count of 1 pending office action is the same for the distinct examiners involved in the laboratory's current applications. With the pending workload and 2 distinct art units, the laboratory's prosecution activity shows a technical footprint within the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEVEAU ROSEN, JASON | 1 | 80.1% | +16.5% |
| ORDAZ, CHRISTIAN JOSE | 1 | 61.1% | +91.7% |
| SULLIVAN, BRIAN JAMES | 1 | 76.9% | +14.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697038 | PLANT DISEASE RESISTANCE GENES AGAINST STEM RUST AND METHODS OF USE | ORDAZ, CHRISTIAN JOSE | 79d overdue |
| 18703392 | MODIFYING THE IMMUNE RESPONSE IN PLANTS | DEVEAU ROSEN, JASON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697038 | PLANT DISEASE RESISTANCE GENES AGAINST STEM RUST AND METHODS OF USE | ORDAZ, CHRISTIAN JOSE | 79d overdue |
| 18703392 | MODIFYING THE IMMUNE RESPONSE IN PLANTS | DEVEAU ROSEN, JASON | — |
| 18267631 | METHODS FOR TARGETED PROTEIN DEGRADATION | SULLIVAN, BRIAN JAMES | — |
| Art Unit | Apps |
|---|---|
| 1663 | 2 |
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703392 | MODIFYING THE IMMUNE RESPONSE IN PLANTS | DEVEAU ROSEN, JASON | 1662 | §102§112 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18697038 | PLANT DISEASE RESISTANCE GENES AGAINST STEM RUST AND METHODS OF USE | ORDAZ, CHRISTIAN JOSE | 1663 | §101§102§112 | Final Rejection | 79d overdue | Pending | Mar 29, 2024 |
| 18267631 | METHODS FOR TARGETED PROTEIN DEGRADATION | SULLIVAN, BRIAN JAMES | 1663 | §103 | Non-Final OA | — | Pending | Jun 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial